| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |